de Bono, Johann S. et al
"Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss." Clinical Cancer Research
25.3
(2019):
928-936.
Web. 17 Feb. 2019.
